Coronavirus Update: Japan Approves Sotrovimab

Plus, Indian Trial For Novavax/Serum Vaccine

 
• By Ian Haydock and Vibha Ravi

Japan approves a second antibody therapy for COVID-19 in short order, while India gives the go-ahead to a local clinical program for Novavax/Serum Institute's recombinant protein vaccine candidate. 

YES and NO acceptance and rejection symbols vector for vote, election choice. Brush painted symbolic approval icons in square frames. Tick and cross signs, check marks graphic design. - Vector
Japan Nod for second antibody therapy for COVID-19 • Source: Shutterstock

More from COVID-19

More from Scrip